Interferon beta 1a (inhalation)

干扰素β 1a（吸入型）

Report date: 2022/07/04 19:38:02

Base Information

Drug NameInterferon beta 1a (inhalation)
Drug Alias Name倍他干扰素-1a（Synairgen）SNG-001AZD-9412
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunomodulatorsInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Pulmonary Disease, Chronic ObstructiveAsthma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesRomania +[17] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Southampton
China Registration ClassN/A

Develop Information

Active CompaniesSynairgen Research Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Pneumonia, Viral
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG